| Date | Title | Description |
| 11.01.2026 | Prudentia Sciences Secures $20 Million Series A. AI Due Diligence Transforms Life Sciences Deals. | Prudentia Sciences raised $20 million in Series A funding. This capital empowers its AI-native platform. The platform streamlines life sciences due diligence. It helps pharmaceutical companies, biotechs, and financial institutions. They eva... |
| 09.01.2026 | Prudentia Sciences: $20 Million Series A Raised To Speed Life Sciences Deal Diligence | Prudentia Sciences announced it raised $20 million in Series A financing to expand its AI-native due diligence platform for life sciences dealmaking, aiming to help pharmaceutical companies, biotechs, and financial institutions evaluate the... |
| 07.01.2026 | Prudentia Sciences Raises $20M in Series A Funding | Prudentia Sciences, a Cambridge, MA-based company which specializes in AI-native due diligence for life sciences dealmaking, raised $20M in Series A funding.
The round was led by McKesson Ventures with participation from SignalFire. Existin... |
| 12.01.2025 | Prudentia Sciences: AI-Based Life Sciences Marketplace Company Raises $7 Million | Prudentia Sciences, an AI-based technology platform for life sciences, announced its public launch, supported by $7 million in funding. This funding round was led by GV, with participation from Iaso Ventures and Virtue.
The company aims to ... |
| 11.01.2025 | Prudentia Sciences: A New Dawn in Life Sciences Dealmaking | In the bustling corridors of Cambridge, Massachusetts, a new player is making waves in the life sciences arena. Prudentia Sciences has emerged with a mission: to revolutionize how biopharma companies navigate the complex world of drug devel... |
| 09.01.2025 | Prudentia Sciences Raises $7M in Funding | Prudentia Sciences, a Cambridge, MA-based provider of an AI-powered technology platform for life sciences, raised $7M in funding.
The round was led by GV, with participation from Iaso Ventures and Virtue.
The company intends to use the fund... |
| 09.01.2025 | Prudentia Sciences Launches with $7M in Funding to Transform the Life Sciences Marketplace for Dealmaking | CAMBRIDGE, Mass.–(BUSINESS WIRE)–January 9, 2025–
Prudentia Sciences, an AI-powered technology platform for life sciences announced today its public launch, supported by $7 million in funding. The funding round was led by GV, with participa... |
| - | Prudentia Sciences | “Accelerated Insights, Prudent Decisions. We are redefining biopharma asset identification, diligence, and valuation processes, ensuring your team stays ahead in a competitive and rapidly evolving market.” |
